The Ministry of Food and Drug Safety (MFDS) announced on the 23rd that the 'Food and Drug Regulatory Innovation 3.0 Tasks' announced in May last year have completed 64 out of a total of 80 tasks within 8 months, achieving an 80% implementation rate.
From 2022 to last year, the MFDS identified a total of 260 regulatory innovation tasks in three phases, of which 231 tasks, or 89%, have been completed or institutionalized.
Among the major achievements of the Food and Drug Regulatory Innovation 3.0 tasks, the MFDS highlighted the establishment of safety management certification standards for automated food devices, the preparation of guidelines for the usage period labeling of personal blood glucose test strips, the development of approval and review guidelines for generative AI medical devices, the increase of the medical expense ceiling for patients receiving compensation for adverse drug reactions, and the construction of an AI-based representative MFDS website.
Oh Yu-kyung, Commissioner of the MFDS, stated, "The MFDS's efforts for regulatory innovation will continue this year as well," adding, "We will concentrate all our capabilities to ensure that the public can quickly feel the effects of regulatory innovation in their daily lives, and the industry can experience them in the industrial field."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
